U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...

The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

Mitsubishi UFJ Financial Group's dividend yield and buyback program boost value. Learn why MUFG stock is a solid investment ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Japan's Mitsubishi Corp posted on Thursday a 19% increase in nine-month net profit to December to 827.4 billion yen ($5.43 ...

The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...

"Mitsubishi reviews offshore wind in Japan amid economic challenges" was originally created and published by Power Technology ...

Mitsubishi Corp on Monday said it is reviewing how to proceed with its offshore wind projects in Japan given a "significantly ...

TOKYO (Reuters) - Demand for gas turbines should remain solid even if data centres require less electricity, Mitsubishi Heavy ...

Mitsubishi Corp has recorded an impairment charge of Y52.2bn ($342.4m) on its offshore wind projects in Japan.

Mitsubishi Motors is facing a tough financial year, with the company slashing its net profit forecast by a staggering 76%.

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...